The NPM1 gene helps cells control growth, protect DNA, and build the small parts needed to make proteins. If it does not work normally, cells can lose some of that control and may start growing in abnormal ways. Some people first learn about this gene when testing for acute myeloid leukemia, because acquired variants in the NPM1 gene are common in this blood cancer and help doctors classify it. These variants usually arise in blood cells during life rather than being inherited from a parent.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some provide the directions for building proteins, which are the parts of cells that do much of the work. Others are mainly involved in controlling when certain processes happen, where they happen, and how active they are. Taken together, genes affect how your body grows and works, and they can also influence how you respond to food, stress, and medicines. For a deeper look at this subject, you can find more in the LearnHub.
Overview
NPM1Gene function
What if the gene works
The NPM1 gene helps cells make ribosomes, the structures that build proteins. It also supports normal cell growth and division and helps move certain proteins to the right place inside the cell.
Risk
What if the gene does not work
Acquired variants in the NPM1 gene are strongly linked to acute myeloid leukemia. Different variants can shift the NPM1 protein out of its usual place in cells, which may influence how the leukemia develops and which features are more noticeable.
Treatment
What does that mean for your treatment
No treatment that specifically targets the NPM1 gene is currently established. In acute myeloid leukemia, a pathogenic variant in the NPM1 gene helps guide risk grouping and post remission planning, especially with FLT3 status and measurable residual disease (tiny amounts of leukemia left after treatment). Treatments aimed at NPM1 are under study, but they are not yet standard care.
Conditions associated with NPM1
Gene function
What if the gene works
In many cells, the NPM1 gene supports busy everyday tasks inside the nucleus. It helps build ribosomes, organize key cell structures, and move certain molecules to the right place. Understanding how the NPM1 gene works in healthy cells makes its role easier to picture.
The NPM1 gene helps the nucleolus, a small area inside the nucleus, process ribosomal RNA and assemble ribosome parts. Ribosomes are the structures your cells use to make proteins.
Its protein moves between the nucleus and the cell fluid, carrying selected proteins and RNA. This traffic helps different parts of the cell stay coordinated.
NPM1 helps manage histones (proteins that DNA wraps around) so genetic material stays neatly packed but still usable. This supports normal gene activity during everyday cell work.
NPM1 helps control centrosomes, structures that help separate chromosomes during cell division. This supports orderly timing as cells prepare to divide.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help explain normal differences between people, such as appearance, metabolism, or the way the body responds to environmental influences. Many do not cause any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant changes how a gene works to a greater degree and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Exactly how variants influence the NPM1 gene's function depends on the change itself. Some variants slightly weaken protein stability or binding, while more disruptive changes alter the protein tail and move NPM1 out of the nucleus into the main body of the cell. This misplacement can disturb cell control signals and, in acute myeloid leukemia, is often linked to a larger role in leukemia growth.
How variants are linked to conditions
Acquired pathogenic variants in the NPM1 gene are most strongly linked to acute myeloid leukemia. In this setting, NPM1 gene variants and acute myeloid leukemia are closely connected, and finding the variant in leukemia cells helps classify a specific subtype of the disease. Variants in the NPM1 gene can also appear in some related blood cancers, but acute myeloid leukemia is the main well established association.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, particularly when several genes and environmental factors play a part. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the NPM1 gene itself. Many NPM1 changes linked to acute myeloid leukemia happen over time in bone marrow cells rather than being inherited, and overall leukemia risk can also be affected by things like older age, prior chemotherapy or radiation, and benzene exposure.
Inheritance of NPM1 variants
There is not yet a broadly confirmed inherited disease pattern for the NPM1 gene in the way seen with classic autosomal dominant or autosomal recessive conditions. In practice, many clinically important NPM1 changes are found only in blood or bone marrow cells and are not passed from parent to child, which is central to understanding how NPM1 gene variants are inherited. The NPM1 gene is located on chromosome 5, which is an autosome, so each person inherits one copy from each parent.
What does my NPM1 result mean for my family?
There is not a broadly confirmed inherited pattern tied to most NPM1 results. Many NPM1 changes found in acute myeloid leukemia happen only in blood cells during life, so they usually do not mean close relatives carry the same change. If you have a specific NPM1 result and questions about what it could mean for your family, a doctor or genetic counselor can explain it in the context of your test.
Genetic information
Genetic testing
How you find out about variants
NPM1 genetic testing in acute myeloid leukemia usually looks for variants in leukemia cells using blood or, more often, bone marrow samples. Labs analyze DNA from the NPM1 gene with methods such as PCR or next generation sequencing to identify a variant and help classify the leukemia and follow response over time.
When should I consider getting a genetic test?
Testing for NPM1 is usually considered when a fast-growing blood cancer called acute myeloid leukemia is suspected or already diagnosed, because changes in this gene can help confirm the type of leukemia and guide follow-up. It is not usually used as an inherited family-risk test.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains varies based on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best interpreted alongside other aspects of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help make individual experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is broken down, how strongly it acts, or how sensitive your body is to it. This helps explain why the same treatment works well for one person, seems less effective for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics looks at how inherited genetic differences can shape a person’s response to medication. It examines links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect both how strongly a drug works and how the body handles it. This understanding can support treatment decisions that are more informed and more personalized. You can read more about this topic in the LearnHub.
Drugs influenced by the NPM1 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in predicting how people respond to medicines, so general questions about side effects, new symptoms, or treatment changes are best discussed with your doctor. In practice, NPM1 is mainly used in blood cancer care to help guide leukemia treatment planning and follow-up, rather than to predict routine medication response.
History
The NPM1 gene entered cancer genetics through studies of a protein first described in the 1970s and 1980s in the cell’s nucleus. Early work linked it to chromosome changes seen in rare lymphomas, which helped researchers recognize that the NPM1 gene could be involved in blood cancers. A major turning point came in 2005, when variants in the NPM1 gene were identified as a common finding in acute myeloid leukemia, especially in cases with a normal-looking set of chromosomes under the microscope. From these first observations, research expanded steadily. That discovery changed leukemia classification and risk assessment, and it remains one of the best-known genetic findings in AML. Today, NPM1 testing is a routine part of evaluating many people with this leukemia.